Trial Profile

Phase III trial of AN 2728 in patients with mild-to-moderate plaque-type psoriasis.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 09 Feb 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Crisaborole (Primary)
Indications Psoriasis
Focus Registrational; Therapeutic Use

Most Recent Events

07 Feb 2012 Planned iniatiation date deferred due to company's intention to focus on development for atopic dermatitis, according to an Anacor Pharmaceuticals media release.
23 Mar 2011 Planned initiation date changed to 1 Dec 2011.
16 Jun 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com